Vaccines

Featured

Realistic portrayal of the scientific community needed to combat science denial

With the recent release of the movie “Vaxxed: From Cover-Up to Catastrophe,” I’m seeing a few blog posts and articles pop up about the hegemonic Read More

Science, global health, and irrational health behaviors

Ed. Note: Sara Gorman will be joining us once a month to highlight different aspects of her forthcoming book on science denialism.  Have you ever Read More

Lifting the Patent Barrier to New Drugs and Energy Sources – The New York Times

Strict patents on technology have had the effect of hindering global progress in some fields, especially in combating disease and climate change. Source: Lifting the Read More

Latest

WHO, Partners To Launch Vaccination Campaigns In Yemen, Northeastern Nigeria To Combat Cholera…

Agence France-Presse: WHO urges Yemen to accept vaccines as cholera crisis deepens “The World Health Organization on Monday urged Yemen to approve cholera vaccinations it has offered to help contain an epidemic that could affect nearly a million people by year’s end…” (9/18). Reuters: WHO plans global war on cholera as Yemen caseload nears 700,000…More


Universal Flu Vaccine Could Protect Against Seasonal, Pandemic Influenza Viruses

Scientific American: 100 Years after the Lethal 1918 Flu Pandemic, We Are Still Vulnerable Catharine I. Paules, medical officer in the Office of the Director at the NIH’s National Institute of Allergy and Infectious Diseases (NIAID), and Anthony S. Fauci, director of NIAID “…[W]e must reexamine our approach to influenza vaccines so we can avert…More


Sanofi Halts Zika Vaccine Research But Other Candidate Vaccines Move Forward In Development

CNN: Sanofi stops work on Zika vaccine while others forge forward “French pharmaceutical giant Sanofi SA paused development of a Zika virus vaccine candidate in response to funding cuts by the U.S. government, the company said in a statement on its website last week. … ‘Right now, there’s no indication that Sanofi is anything other…More


Gates Foundation Grants $120M To PATH For Vaccine R&D, Deployment

GeekWire: PATH receives $120M Gates Foundation grant to fuel vaccine development across the globe “Seattle-based global health nonprofit PATH announced Wednesday that it has received a $120 million grant from the Bill & Melinda Gates Foundation aimed at fueling the organization’s development and deployment of life-saving vaccines. The funds will go to the PATH Center…More


Sanofi Ends Research Into 2 Experimental Zika Vaccines After U.S. Funding Focus Shifts

Wall Street Journal: Sanofi Stops Work on Two Zika Vaccines “Drugmaker Sanofi SA has ended its development of two Zika virus vaccines, citing a decline in new infections and limits on U.S. government funding, in a move that illustrates the challenges in sustaining research in emerging infectious diseases after major outbreaks subside…” (Loftus, 9/6).


CEPI Call For Proposals Aims To Identify ‘New Approaches To Vaccine Development’

Devex: CEPI announces call for proposals to innovate vaccines “With a call for proposals on Tuesday, the Coalition for Epidemic Preparedness Innovations aims to shorten the usually long time it takes to develop vaccines for emerging diseases. This call, open to a range of companies, foundations, and research and development institutions, asks for ideas for…More


CSIS Podcast Episodes Discuss Immunization, IAS 2017, Global Health R&D, Global TB, Health…

Center for Strategic & International Studies’ “Take As Directed”: What are the barriers to reaching children with immunizations? Nellie Bristol, senior fellow at the Global Health Policy Center at CSIS, speaks with Jon Kim Andrus, adjunct professor and senior investigator in the Division of Vaccines and Immunization at the University of Colorado, and Lora Shimp,…More


Sanofi Pasteur Signals End Of Experimental Zika Vaccine Research

STAT: Sanofi quietly pulls the plug on its Zika vaccine project “Vaccine giant Sanofi Pasteur has quietly pulled the plug on its Zika vaccine project, a move that underscores how difficult it may be at this stage to develop a vaccine against the virus. … While a number of experimental Zika vaccines are at various…More


More Ambitious Health Targets Needed To Achieve SDG 3

Devex: Opinion: We need more ambitious global health targets Seth Berkley, CEO of Gavi, the Vaccine Alliance “…A lack of ambition in how we measure progress toward … [Sustainable Development Goal (SDG) 3 targets, which include ending preventable under-five deaths and achieving universal health coverage with access to affordable and essential vaccines for all,] will…More


WHO Must Take Steps To Minimize Toll Of Cholera Outbreak In Yemen

PLOS Blogs’ “Speaking of Medicine”: Cholera in Yemen: Why are vaccines not being used? Lorenz von Seidlein, PLOS Medicine’s specialty consulting editor, discusses the current cholera outbreak in Yemen, including the lack of vaccinations in the region, and urges the WHO to provide technical and political leadership to respond to the situation (8/2).


Wider Use Of Vaccines Could Help Address, Prevent Antibiotic Resistance

STAT: Vaccines are part of the solution to the emerging crisis of antibiotic resistance Bruce Gellin, president of global immunization at the Sabin Vaccine Institute “…[I]n the context of the global trend in antibiotic resistance, we have been undervaluing all that vaccines offer to both individuals and communities. … Vaccines help prevent the rise of…More


Global Community Must Continue To Invest In Vaccines, Strengthen Immunization Systems

Devex: Opinion: Vaccination rates are high — but they’re not high enough Orin Levine, director of vaccine delivery at the Bill & Melinda Gates Foundation, and Mike Osterholm, director of the Center for Infectious Disease Research and Policy “…Here’s what we see in this year’s [WHO/UNICEF report on global immunization coverage]: overall high but stagnating…More


Vaccination remains the most cost-effective strategy to get on track with hepatitis B…

Midwife providing the 5-in-1 pentavalent vaccine (diphtheria-tetanus-pertussis [DTP], hepatitis B, and Haemophilus influenzae type b) during a routine vaccination session in Myanmar Dr. Rania Tohme, Team Lead, Global Immunization Division, CDC In the 1990s, the Western Pacific Region had one of the highest prevalence rates of chronic hepatitis B infection in the world (>8%). As a result, in 2005, it was the first World Health Organization (WHO) Region to adopt a hepatitis B control goal through vaccination. With the financial support of GAVI (the Vaccine Alliance), countries in the region introduced hepatitis B vaccine into routine immunization, starting with a birth dose followed by 2-3 additional doses.


WHO, UNICEF Immunization Experts Discuss Recent Report On DTP Vaccine Coverage On NPR

NPR: New Report Shows 64 Of 195 Countries Aren’t Meeting A Basic Vaccination Target “Vaccine progress is stalling. That’s the message from a new report issued by the World Health Organization and UNICEF. The report focuses on the [diphtheria, tetanus, and pertussis (DTP)] vaccine … We spoke with Jean-Marie Okwo-Bele, director of immunization, vaccines, and…More


« Newer PostsOlder Posts »